Assessment & Research

Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment.

Sansone et al. (2012) · Journal of autism and developmental disorders 2012
★ The Verdict

Use the six-factor FXS-ABC-C to catch Social Avoidance and cut trial size.

✓ Read this if BCBAs who test meds or run skill trials with fragile X clients.
✗ Skip if Clinicians who only serve idiopathic ASD or adults without FXS.

01Research in Context

01

What this study did

The team took the Aberrant Behavior Checklist and ran it through the kids with fragile X.

They used stats to see which questions clump together.

Goal: build a version that spots fragile X quirks the old form misses.

02

What they found

Six clean factors popped out.

One new factor, Social Avoidance, showed up only in fragile X.

The new form catches change better, so drug trials need fewer kids to see an effect.

03

How this fits with other research

Morris et al. (2021) also rebuilt an assessment tool. They modeled self-injury sub-types to explain why some FA graphs look weird.

Becraft et al. (2020) give you the math to pool single-case data. You can plug the FXS-ABC-C into their meta-analysis template.

Williams et al. (2019) sweep Russian ASD practice into one review. Their paper covers the years after this scale came out, so clinics there could adopt the six-factor form right now.

04

Why it matters

If you run medication or skill-building trials in fragile X, swap to the six-factor ABC-C today. You will measure Social Avoidance, the first thing parents notice but old forms ignore. Smaller, faster trials mean quicker access to meds that actually help.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Download the FXS-ABC-C scoring sheet and add Social Avoidance items to your intake packet.

02At a glance

Intervention
not applicable
Design
other
Sample size
630
Population
developmental delay
Finding
positive

03Original abstract

Animal studies elucidating the neurobiology of fragile X syndrome (FXS) have led to multiple controlled trials in humans, with the Aberrant Behavior Checklist-Community (ABC-C) commonly adopted as a primary outcome measure. A multi-site collaboration examined the psychometric properties of the ABC-C in 630 individuals (ages 3-25) with FXS using exploratory and confirmatory factor analysis. Results support a six-factor structure, with one factor unchanged (Inappropriate Speech), four modified (Irritability, Hyperactivity, Lethargy/Withdrawal, and Stereotypy), and a new Social Avoidance factor. A comparison with ABC-C data from individuals with general intellectual disability and a list of commonly endorsed items are also reported. Reformulated ABC-C scores based on this FXS-specific factor structure may provide added outcome measure specificity and sensitivity in FXS clinical trials.

Journal of autism and developmental disorders, 2012 · doi:10.1007/s10803-011-1370-2